Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Nature Protocols|December 9, 2022
High-quality and robust protein quantification in large clinical/pharmaceutical cohorts with IonStar proteomics investigationShichen Shen, Xue Wang, Xiaoyu Zhu, et al.
BMJ Open|July 24, 2025
Future exacerbations and mortality rates among patients experiencing COPD exacerbations: a meta-analysis of results from the EXACOS/AVOIDEX programmeKirsty Rhodes, Deven Patel, My Linh Duong, et al.
Plos One|March 29, 2017
Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled TrialRobert A Wise, Janet T Holbrook, Gerard Criner, et al.
Plos One|November 11, 2016
Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled TrialRobert A Wise, Janet T Holbrook, Gerard Criner, et al.
European Journal of Internal Medicine|August 13, 2025
A person-centred clinical approach to the multimorbid patient with COPDBartolome R Celli, Leonardo M Fabbri, Abebaw M Yohannes, et al.
American Journal of Respiratory and Critical Care Medicine|May 16, 2018
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized TrialsFernando J Martinez, Klaus F Rabe, Peter M A Calverley, et al.
Alternatives to Laboratory Animals : ATLA|June 4, 2016
Assessment of in vitro COPD models for tobacco regulatory science: Workshop proceedings, conclusions and paths forward for in vitro model useHolger Behrsing, Hans Raabe, Joseph Manuppello, et al.
BMC Genomics|July 20, 2013
Design and validation of a supragenome array for determination of the genomic content of Haemophilus influenzae isolatesRory A Eutsey, N Luisa Hiller, Joshua P Earl, et al.
Thorax|February 10, 2012
Significance of the microbiome in obstructive lung diseaseMeilan K Han, Yvonne J Huang, John J Lipuma, et al.
The Journal of Clinical Investigation|May 18, 2011
Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in miceMatthias Clauss, Robert Voswinckel, Gangaraju Rajashekhar, et al.
Pageof 18